Literature DB >> 19242838

Characterization of bone marrow-derived mesenchymal stromal cells (MSC) based on gene expression profiling of functionally defined MSC subsets.

Ariane Tormin1, Jan C Brune, Eleonor Olsson, Jeanette Valcich, Ulf Neuman, Tor Olofsson, Sten-Eirik Jacobsen, Stefan Scheding.   

Abstract

BACKGROUND AIMS: Human mesenchymal stromal cells (MSC) are promising candidates for cell therapy because of their intriguing properties (high proliferation and differentiation capacity, microenvironmental function and immune modulation). However, MSC are heterogeneous and a better understanding of the heterogeneity of the cells that form the MSC cultures is critical.
METHODS: Human MSC were generated in standard cultures and stained with carboxyfluorescein succinimidyl ester (CFSE) for cell division tracking. Gene expression profiling of MSC that were sorted based on functional parameters (i.e. proliferation characteristics) was utilized to characterize potential MSC subpopulations (progenitor content and differentiation capacity) and identify potential MSC subpopulation markers.
RESULTS: The majority of MSC had undergone more than two cell divisions (79.7+/-2.0%) after 10 days of culture, whereas 3.5+/-0.9% of MSC had not divided. MSC were then sorted into rapidly dividing cells (RDC) and slowly/non-dividing cells (SDC/NDC). Colony-forming unit-fibroblast (CFU-F) frequencies were lowest in NDC and highest in RDC with low forward-/side-scatter properties (RDC(lolo)). Comparative microarray analysis of NDC versus RDC identified 102 differentially expressed genes. Two of these genes (FMOD and VCAM1) corresponded to cell-surface molecules that enabled the prospective identification of a VCAM1(+)/FMOD(+) MSC subpopulation, which increased with passage and showed very low progenitor activity and limited differentiation potential.
CONCLUSIONS: These data clearly demonstrate functional differences within MSC cultures. Furthermore, this study shows that cell sorting based on proliferation characteristics and gene expression profiling can be utilized to identify surface markers for the characterization of MSC subpopulations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19242838     DOI: 10.1080/14653240802716590

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  29 in total

1.  Tumorigenicity analysis of heterogeneous dental stem cells and its self-modification for chromosome instability.

Authors:  Zhaosong Meng; Guoqing Chen; Jinlong Chen; Bo Yang; Mei Yu; Lian Feng; Zongting Jiang; Weihua Guo; Weidong Tian
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Engineering bone tissue substitutes from human induced pluripotent stem cells.

Authors:  Giuseppe Maria de Peppo; Iván Marcos-Campos; David John Kahler; Dana Alsalman; Linshan Shang; Gordana Vunjak-Novakovic; Darja Marolt
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-07       Impact factor: 11.205

3.  CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization.

Authors:  Ariane Tormin; Ou Li; Jan Claas Brune; Stuart Walsh; Birgit Schütz; Mats Ehinger; Nicholas Ditzel; Moustapha Kassem; Stefan Scheding
Journal:  Blood       Date:  2011-03-17       Impact factor: 22.113

4.  Molecular characterization of prospectively isolated multipotent mesenchymal progenitors provides new insight into the cellular identity of mesenchymal stem cells in mouse bone marrow.

Authors:  Hong Qian; Aurora Badaloni; Francesca Chiara; Jenny Stjernberg; Naresh Polisetti; Kristian Nihlberg; G Giacomo Consalez; Mikael Sigvardsson
Journal:  Mol Cell Biol       Date:  2012-11-26       Impact factor: 4.272

Review 5.  Mesenchymal stem cell subpopulations: phenotype, property and therapeutic potential.

Authors:  Miaohua Mo; Shan Wang; Ying Zhou; Hong Li; Yaojiong Wu
Journal:  Cell Mol Life Sci       Date:  2016-05-03       Impact factor: 9.261

6.  Cytohesin 1 regulates homing and engraftment of human hematopoietic stem and progenitor cells.

Authors:  Justyna Rak; Katie Foster; Katarzyna Potrzebowska; Mehrnaz Safaee Talkhoncheh; Natsumi Miharada; Karolina Komorowska; Therese Torngren; Anders Kvist; Åke Borg; Lena Svensson; Dominique Bonnet; Jonas Larsson
Journal:  Blood       Date:  2016-11-29       Impact factor: 22.113

7.  Distinct stem cells subpopulations isolated from human adipose tissue exhibit different chondrogenic and osteogenic differentiation potential.

Authors:  Tommaso Rada; Rui L Reis; Manuela E Gomes
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

8.  Clonal analysis of the proliferation potential of human bone marrow mesenchymal stem cells as a function of potency.

Authors:  Katie C Russell; Michelle R Lacey; Jennifer K Gilliam; H Alan Tucker; Donald G Phinney; Kim C O'Connor
Journal:  Biotechnol Bioeng       Date:  2011-05-10       Impact factor: 4.530

Review 9.  Toward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors.

Authors:  Daniel Bexell; Stefan Scheding; Johan Bengzon
Journal:  Mol Ther       Date:  2010-04-20       Impact factor: 11.454

10.  Human bone marrow stromal cell confluence: effects on cell characteristics and methods of assessment.

Authors:  Jiaqiang Ren; Huan Wang; Katherine Tran; Sara Civini; Ping Jin; Luciano Castiello; Ji Feng; Sergei A Kuznetsov; Pamela G Robey; Marianna Sabatino; David F Stroncek
Journal:  Cytotherapy       Date:  2015-04-14       Impact factor: 5.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.